Stock futures rose slightly on Monday after a stellar previous week as recent positive economic data eased inflation and recession concerns. However, investors remain cautious as they await the Federal Reserve’s meeting minutes and the Jackson Hole symposium for insights on the central bank. The bank’s future interest rate strategy.

Here are some of Monday’s biggest stock market moves:

The biggest stock winners

• FuboTV (NYSE:FUBO) Shares rose up to 13% in premarket trading Monday, building on Friday’s 17% gain after a federal judge temporarily blocked the launch of a rival sports streaming service. The $42.99-a-month venture, backed by Fox, Warner Bros. Discovery and Walt Disney, was scheduled to launch next week but was halted amid a lawsuit from FuboTV alleging anti-competitive practices. The company argues the new service would have hampered competition and harmed consumers.
• ZIM Integrated Shipping Services (NYSE: ZIM) Shares rose by over 15% after the company delivered a strong second quarter performance and significantly raised its full-year guidance. The shipping giant reported a record 11% year-on-year volume increase, coupled with a substantial 40% increase in average freight rate per TEU. In addition, in line with dividend policy, the company announced a dividend of $0.93 per share, representing 30% of second quarter net income. Building on this strong performance, ZIM raised its full-year 2024 guidance for Adjusted EBITDA to $2.6 billion to $3 billion and Adjusted EBIT to $1.45 billion to $1.85 billion.
• Advanced Micro Devices (NASDAQ: AMD) Shares rose by over 3% after announcing the acquisition of AI infrastructure provider ZT Systems for approximately $4.9 billion in cash and stock. The goal of the deal is to strengthen AMD’s data center and AI system capabilities by leveraging ZT Systems’ expertise in developing and optimizing cloud computing solutions. This strategic move positions AMD as a strong competitor in the AI ​​market and complements its existing portfolio of high-performance AI accelerators, CPUs and networking products. The acquisition is expected to close in H1 2025 and be accretive to AMD’s financial performance by the end of 2025.
• Emergent BioSolutions (NYSE: EBS) Stocks continued their upward trend, Increase of 6% Monday, after rising 24% in the previous session. The company, which makes the smallpox vaccine ACAM2000, is benefiting from growing concerns about Mpox. The WHO’s recent declaration of a global health emergency over the virus has fueled investor optimism, while Emergent seeks FDA approval to expand the use of its vaccine to include Mpox protection.

The biggest stock losers

• ShakeShack (NYSE: SHAK) Shares fell by approx. 3%while Dutch Bros (NYSE: BROS) dropped around 4% in premarket trading after Piper Sandler downgraded both fast-casual restaurant chains to Neutral from Overweight. The broker cited a more balanced risk-reward profile for both companies given current market conditions, but maintained a generally positive outlook.
• Liquidia (NASDAQ: LQDA) shares lost more than a third of their value after the U.S. FDA granted only provisional approval for Yutrepia (treprostinil) to treat pulmonary hypertension associated with interstitial lung disease. This decision delays the potential launch until May 23, 2025, when final approval could be granted. The delay is due to the FDA’s recognition of a three-year regulatory exclusivity for United Therapeutics (.NASDAQ:UTHR) Tyvaso DPI, which was issued on May 23, 2022. Liquidia CEO Roger Jeffs said the company plans to challenge the FDA’s broad grant of regulatory exclusivity to minimize delays in patient access to Yutrepia. The drug previously received tentative approval for pulmonary arterial hypertension (PAH) in November 2021. Liquidia and United Therapeutics are in litigation over Yutrepia because United Therapeutics markets the competing treprostinil drug Tyvaso. United Therapeutics shares rose 5%.